Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more: buff.ly/TUarANa #AACRIO26

The abstract deadline for the AACR Annual Meeting 2026 is 11:59 PM ET on Tuesday, November 18. Submit an abstract and join the cancer research community in San Diego, April 17-22. Learn more: buff.ly/dzZnhJr #AACR26

Karlie Kisha survived cancer, competed in the 2024 Olympic Games, and now has her sights set on running the 8K during the AACR Philadelphia Marathon Weekend with the AACR #Runners4Research. Learn more about her story: buff.ly/PTYRrVa

Some doctors still avoid using hormone therapy in women with gynecologic cancers, and crowdfunding falls short for people with cancer. Read these stories and more from Cancer Today magazine's The Week in Cancer News.

With the AACR Special Conference on Cancer Evolution coming up on December 4-6, the #AACRBlog spoke with conference cochair @marasherman.bsky.social and AACR Cancer Evolution Working Group chair Laura M. Heiser about what to expect: buff.ly/qBq6LgO #AACRevol25

The abstract deadline for the AACR Annual Meeting 2026 is 11:59 PM ET on Tuesday, November 18. Submit an abstract and join the cancer research community in San Diego, April 17-22. Learn more: buff.ly/dzZnhJr #AACR26

Gene Regulatory Mechanisms of Oncoproteins: Stephen Mack, Genevieve Kendall, Eleni Tomazou, and Brian Rubin will address this topic in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia). buff.ly/M5Tpi1K #AACRfusion26 @kendalllab.bsky.social

Tremendous progress against blood cancers in the past decade has significantly decreased blood cancer–related deaths, improved survival rates, and helped survivors live fuller lives. Learn about these advancements in the 2025 AACR #CancerProgressReport: buff.ly/B03pNXi

Register by Dec 15 to get the lowest rates for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter Nelson, Elena Castro, Patrick Pilié, and Eliezer Van Allen. Learn more: buff.ly/EXiV4Yr #AACRprostate26 @vanallenlab.bsky.social

A career development grant from the AACR enabled Yale Cancer's Luisa Escobar-Hoyos, MSc, PhD, to secure two major multi-year federal grants for her pancreatic cancer research: Learn more in #AACRStories: www.aacr.org/about-the-aa... #PancreaticCancerAwarenessMonth

An antibody-drug conjugate led to longer survival for women with early-stage HER2-positive breast when signs of cancer remained after neoadjuvant treatment. Learn more in Cancer Today magazine: buff.ly/tmHFi0Q

Submit an abstract by December 4 for the AACR Special Conference on Innovations in Kidney Cancer Research (March 13-16, 2026; Philadelphia), chaired by Eric Jonasch, M. Celeste Simon, Samra Turajlic, and Qing Zhang. Learn more: buff.ly/IoqbeGk #AACRkidney26 @turajliclab.bsky.social

Promising early-phase clinical trial results for several first-in-class therapeutics with innovative mechanisms of action and cutting-edge technologies were recently presented at #Targets25. Learn more on the #AACRBlog: buff.ly/hNZxH9V

Submit an abstract by November 18 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more: buff.ly/dzZnhJr #AACR26

Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more: buff.ly/TUarANa #AACRIO26

The @US_FDA approved the targeted monoclonal antibody therapy daratumumab and hyaluronidase-fihj as a monotherapy for adults with high-risk smoldering multiple myeloma: buff.ly/41VfCrM

AACR Project GENIE is celebrating its 10th anniversary. Look back at the history, growth, and impact of this publicly accessible cancer registry that continues to support clinical decision-making and advance precision medicine: buff.ly/jNksCvu

Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more: buff.ly/KSYsLWC #AACRras26

In a new episode of the Believe in Progress podcast, Rhett Austell shares his powerful story of facing cancer and recurrence, navigating fatherhood, and finding strength in the fight for his life. Listen to this heartfelt podcast out now: buff.ly/PsCkHGo

The @theaacr.bsky.social–Mark Foundation Chemistry in Cancer Research Grants are now accepting Letters of Intent! We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer. Learn more and apply: www.aacr.org/grants/aacr-...

Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more: buff.ly/MBBHFX7 #AACRprostate26 @vanallenlab.bsky.social

Are you an early-career scientist ready to lead & connect? 🌟 Joining the @theaacr.bsky.social Associate Member Council has shaped my network & allowed me to advocate for scientists like me. Apply now to make an impact! 🔬💪 🗓️ Deadline: Nov 7 👉 Apply here: (lnkd.in/gy7rna6Z) #AACR #ECR #AMC

Alexander Drilon, Jolanta Grembecka, Jessica Jiyeong Lin, and Jia Luo will discuss "Translating Discoveries Toward New Therapies" in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia). Learn more: buff.ly/3jO4l4j #AACRfusion26 @jia-luo.bsky.social

Submit an abstract by November 18 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more: buff.ly/dzZnhJr #AACR26

New findings that adding chemotherapy to osimertinib (Tagrisso) for advanced EGFR-positive non-small cell lung cancer may help clarify options for first-line treatment. Read more in Cancer Today. buff.ly/7zkmjKf

Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more: buff.ly/MBBHFX7 #AACRprostate26 @vanallenlab.bsky.social

Register by November 3 to get the lowest available rates for the San Antonio Breast Cancer Symposium (December 9-12), directed by Carlos L. Arteaga and Virginia G. Kaklamani. Learn more: buff.ly/sLYTMHh #SABCS25

People with a history of polyps often do not get follow-up colonoscopy after a positive FIT test, early-onset cancers are rising in Corn Belt states, and more. Read these stories and more from Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more: buff.ly/MBBHFX7 #AACRprostate26 @vanallenlab.bsky.social

Kamila Naxerova, Laura D. Wood, Silvia C. Formenti, and Marina Pasca di Magliano will discuss "Clinical Translation and Early Detection" in a plenary session at the AACR Special Conference on Cancer Evolution (December 4-6; Albuquerque). Learn more: buff.ly/Rr9vp0r #AACRevol25 @naxerova.bsky.social

New guidelines aim to give more doctors the tools to discuss chemo brain in the clinic. Cancer Today spoke with one of the authors about what to look for and options for managing the condition. www.cancertodaymag.org/fall-2025/re...

Condensates: Fact or Fusion? Danfeng Cai, Miguel Rivera, Lukasz Bugaj, and Natasha Caplen will address this question in a plenary session at the AACR Conference on Fusion-Positive Cancers (January 13-15, 2026; Philadelphia). buff.ly/lomdoSd #AACRfusion26 @danfengcai.bsky.social @bugajlab.bsky.social

Submit an abstract by November 18 for the AACR Annual Meeting 2026 (April 17-22; San Diego), chaired by Paul S. Mischel and Alice T. Shaw. Learn more: buff.ly/dzZnhJr #AACR26

Eliezer M. Van Allen, Stephanie A. Harmon, William R. Sellers, and Ravi B. Parikh will discuss "AI in Prostate Cancer Research" in a plenary session at the AACR Conference on Prostate Cancer Research and Treatment (January 20-22; Boston). buff.ly/FcLP7Ye #AACRprostate26 @vanallenlab.bsky.social

Every woman’s individual breast cancer risk is influenced by a host of factors. Learn more about the latest we know in breast cancer risk and prevention this #BreastCancerAwarenessMonth on the AACR Blog: www.aacr.org/blog/2025/10...

Register by November 3 to get the lowest rates for the AACR Special Conference on Cancer Evolution (December 4-6; Albuquerque), chaired by Mariam Jamal-Hanjani, Kenneth J. Pienta, and Mara H. Sherman and held in association with #AACRCEWG. buff.ly/tW108U2 #AACRevol25 @marasherman.bsky.social

The AACR Grantee Summit brought together scientists whose work is transforming cancer science and medicine. Learn more about TP53 status as a therapy guide, strategies for tackling metastasis, and innovative approaches for rare cancers on the #AACRBlog: buff.ly/qTsyJ2H

Submit an abstract by November 6 for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter S. Nelson, Elena Castro, Patrick G. Pilié, and Eliezer M. Van Allen. Learn more: buff.ly/MBBHFX7 #AACRprostate26 @vanallenlab.bsky.social

Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more: buff.ly/TUarANa #AACRIO26

Submit an abstract by December 4 for the AACR Special Conference on Innovations in Kidney Cancer Research (March 13-16, 2026; Philadelphia), chaired by Eric Jonasch, M. Celeste Simon, Samra Turajlic, and Qing Zhang. Learn more: buff.ly/IoqbeGk #AACRkidney26

Register by November 3 to get the lowest available rates for the San Antonio Breast Cancer Symposium (December 9-12), directed by Carlos L. Arteaga and Virginia G. Kaklamani. Learn more: buff.ly/sLYTMHh #SABCS25 @vkaklamani.bsky.social

"When I was diagnosed almost 15 years ago … I don't think they even knew what HER2-low was back then." Understand the changes in HER2 breast cancer types in the latest issue of Cancer Today. buff.ly/DBmBvkJ

AACR Project GENIE is celebrating its 10th anniversary. Look back at the history, growth, and impact of this publicly accessible cancer registry that is continuing to support clinical decision-making and advance precision medicine: buff.ly/XC6FCZv #AACRGENIE #AACRStories

Ben Raphael, Niko Beerenwinkel, Chris Venditti, and George Butler will discuss "Computational Approaches to Cancer Evolution" in a plenary session at the AACR Special Conference on Cancer Evolution (December 4-6; Albuquerque). Learn more: buff.ly/5kEQyE8 #AACRevol25 @braphael.bsky.social

Abstract submission is now open for the AACR Annual Meeting 2026 (April 17-22). Submit your abstract by November 18 and join us in San Diego to share the latest advances in cancer science and medicine. Learn more: buff.ly/dzZnhJr #AACR26

This year's gala honored Lynn M. Schuchter, MD of the @PennCancer; early-career researcher Alexander Huang, MD of @PennMedicine; Humanitarian Honoree Patricia D. Wellenbach, immediate past president and CEO of the Please Touch Museum; and Community Impact Awardee Tara Miller Melanoma Foundation.

This year's Party with a Purpose gala raises vital support for melanoma research. We thank the Friends of the AACR Foundation organizing committee for putting together this fantastic event and all the attendees for helping to drive progress and save more lives from cancer.

An investigational inhibitor of active KRAS G12C showed promise for patients with metastatic NSCLC, including for those whose tumors had features consistent with resistance to other KRAS G12C inhibitors, according to clinical trial results reported at #Targets25. buff.ly/7ZvDYDK

The HER2/HER3-targeted bispecific antibody zenocutuzumab was associated with a 37% overall response rate in patients with a rare cholangiocarcinoma enrolled in the eNRGy phase II clinical trial, as reported at #Targets25. buff.ly/2ef2d6n

An investigational DLL3-targeting antibody-drug conjugate, ZL-1310, showed safety and anticancer responses in patients with extensive-stage small cell lung cancer. Grace K. Dy, MD, of @roswellpark.bsky.social presented phase I clinical trial results at #Targets25. buff.ly/iZCWaXU